News
Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025). The ...
The European Migraine and Headache Alliance (EMHA) has urged EU policymakers to include migraine in the forthcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback